blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2793886

EP2793886 - AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  10.09.2021
Database last updated on 03.04.2025
Most recent event   Tooltip17.09.2021Revocation of patentpublished on 20.10.2021  [2021/42]
Applicant(s)For all designated states
Teva Branded Pharmaceutical Products R & D, Inc.
41 Moores Road
Frazer, Pennsylvania 19355 / US
[2016/45]
Former [2016/34]For all designated states
Teva Branded Pharmaceutical Products R & D, Inc.
425 Privet Rd
Horsham, PA 19044 / US
Former [2014/44]For all designated states
Teva Branded Pharmaceutical Products R & D, Inc.
425 Privet Rd
Horsham, PA 19044 / US
Inventor(s)01 / ZENG, Xian-Ming
Teva Branded Pharmaceutical Products R & D, Inc.
74 NW 176 Street
Miami, FL 33169-5043 / US
 [2014/44]
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[N/P]
Former [2016/34]Gillard, Richard Edward
Elkington and Fife LLP
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Former [2014/44]Cottam, David William
Teva Global Patent Group
Field House Station Approach
Harlow Essex CM20 2FB / GB
Application number, filing date12806382.306.12.2012
[2016/34]
WO2012EP74690
Priority number, dateUS201161577315P19.12.2011         Original published format: US 201161577315 P
GB2012000052513.01.2012         Original published format: GB 201200525
[2014/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013092237
Date:27.06.2013
Language:EN
[2013/26]
Type: A1 Application with search report 
No.:EP2793886
Date:29.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 27.06.2013 takes the place of the publication of the European patent application.
[2014/44]
Type: B1 Patent specification 
No.:EP2793886
Date:24.08.2016
Language:EN
[2016/34]
Search report(s)International search report - published on:EP27.06.2013
ClassificationIPC:A61K31/46, A61K9/00, A61K47/10, A61K47/12, A61M15/00, A61P11/00
[2016/09]
CPC:
A61K9/008 (EP,KR,US); A61K47/12 (KR,US); A61K31/439 (KR,US);
A61K31/46 (EP,KR,US); A61K47/10 (KR,US); A61M15/009 (KR,US);
A61P11/00 (EP,US) (-)
Former IPC [2014/44]A61K31/46, A61K9/00, A61K9/12, A61P11/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:INHALIERBARES MEDIKAMENT ENTHALTEND TIOTROPIUM[2016/09]
English:AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM[2014/44]
French:COMPOSITION PHARMACEUTIQUE INHALABLE COMPRENANT DU TIOTROPIUM[2016/09]
Former [2014/44]INHALIERBARES ARZNEIMITTEL MIT TIOTROPIUM
Former [2014/44]MÉDICAMENT INHALABLE COMPRENANT DU TIOTROPIUM
Entry into regional phase27.06.2014National basic fee paid 
27.06.2014Designation fee(s) paid 
27.06.2014Examination fee paid 
Examination procedure27.06.2014Examination requested  [2014/44]
25.02.2015Amendment by applicant (claims and/or description)
07.05.2015Despatch of a communication from the examining division (Time limit: M06)
17.11.2015Reply to a communication from the examining division
08.03.2016Communication of intention to grant the patent
18.07.2016Fee for grant paid
18.07.2016Fee for publishing/printing paid
18.07.2016Receipt of the translation of the claim(s)
Divisional application(s)EP16185402.1  / EP3143998
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.05.2015
Opposition(s)Opponent(s)01  24.05.2017    ADMISSIBLE
3M United Kingdom plc
3M Centre
Cain Road
Bracknell
Berkshire RG12 8HT / GB
Opponent's representative
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
 [2017/27]
05.07.2017Invitation to proprietor to file observations on the notice of opposition
12.01.2018Reply of patent proprietor to notice(s) of opposition
12.11.2018Date of oral proceedings
10.12.2018Despatch of interlocutory decision in opposition
10.12.2018Despatch of minutes of oral proceedings
23.07.2021Despatch of communication that the patent will be revoked
02.08.2021Legal effect of revocation of patent [2021/42]
Appeal following opposition20.02.2019Appeal received No.  T0577/19
18.04.2019Statement of grounds filed
12.07.2021Result of appeal procedure: revocation of the patent
23.07.2021Despatch of the decision of the Board of Appeal
Fees paidRenewal fee
22.12.2014Renewal fee patent year 03
22.12.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL24.08.2016
CY24.08.2016
EE24.08.2016
HR24.08.2016
IS24.08.2016
LT24.08.2016
LV24.08.2016
MK24.08.2016
RO24.08.2016
RS24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU06.12.2016
MT06.12.2016
PT26.12.2016
[2018/46]
Former [2018/43]CY24.08.2016
EE24.08.2016
HR24.08.2016
IS24.08.2016
LT24.08.2016
LV24.08.2016
MK24.08.2016
RO24.08.2016
RS24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU06.12.2016
MT06.12.2016
PT26.12.2016
Former [2018/31]CY24.08.2016
EE24.08.2016
HR24.08.2016
IS24.08.2016
LT24.08.2016
LV24.08.2016
MK24.08.2016
RO24.08.2016
RS24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU06.12.2016
PT26.12.2016
Former [2017/49]EE24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
RO24.08.2016
RS24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU06.12.2016
PT26.12.2016
Former [2017/37]EE24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
RO24.08.2016
RS24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/32]EE24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
RO24.08.2016
RS24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/13]HR24.08.2016
LT24.08.2016
LV24.08.2016
RS24.08.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/11]HR24.08.2016
LT24.08.2016
RS24.08.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/09]LT24.08.2016
NO24.11.2016
Former [2017/07]LT24.08.2016
Cited inInternational search[ID]WO9209323  (NORTON HEALTHCARE LTD [GB]) [ID] 11,12 * the whole document ** figures 3-5 *;
 [I]WO2004054580  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [I] 1-17 * the whole document * * page 8; examples A, C, D *;
 [I]WO2011061498  (CIPLA LTD, et al) [I] 1-17 * the whole document * * example II *
by applicantWO9209323
 GB2264238
 WO9413262
 WO0193933
 WO03082252
 US2005058606
 EP1666029
 EP2201934
    - Drug Delivery to the Respiratory Tract, VCH PUBLISHERS, (1987), pages 87 - 88
    - Pharmaceutics - The Science of Dosage Form Design, CHURCHILL LIVINGSTONE, (2002), page 476
OppositionWO9413262
 WO2004054580
 EP2201934
 WO2011061498
 WO2013127738
 EP2606891
    - "Ethanol-Wasser Dichte Dichtetabelle wäßriger Alkohol-Lösungen.", Internet Chemie Lexikon, (20161114), URL: http://www.internetchemie.info/chemiewiki/index.php?title=Ethanol-Wasser-Dichtetabelle, XP055389411
    - "ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS Q1A(R2", INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE, (20030206), pages 1 - 18, XP055268662
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.